Global Hereditary Angioedema Drug Market Research Report 2017

August 2017 | 104 pages | ID: G9933F24D2BEN
QYResearch

Abstracts

In this report, the global Hereditary Angioedema Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Hereditary Angioedema Drug in these regions, from 2012 to 2022 (forecast), covering

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Global Hereditary Angioedema Drug market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

• Pharming Group NV
• Shire plc
• CSL Limited
• iBio Inc.
• BioCryst Pharmaceuticals, Inc.
• Ionis Pharmaceuticals, Inc.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• By Product
• C1 Esterase Inhibitor
• Kallikrein Inhibitor
• Selective Bradykinin B2 Receptor Antagonist
• By Route of Administration
• Oral
• Intravenous
• Subcutaneous Injection

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Hereditary Angioedema Drug for each application, including

• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Hereditary Angioedema Drug Market Research Report 2017

1 HEREDITARY ANGIOEDEMA DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Hereditary Angioedema Drug
1.2 Hereditary Angioedema Drug Segment By Product
  1.2.1 Global Hereditary Angioedema Drug Production and CAGR (%) Comparison By Product (Product Category)(2012-2022)
  1.2.2 Global Hereditary Angioedema Drug Production Market Share By Product (Product Category) in 2016
  1.2.3 C1 Esterase Inhibitor
  1.2.4 Kallikrein Inhibitor
  1.2.5 Selective Bradykinin B2 Receptor Antagonist
1.3 Hereditary Angioedema Drug Segment By Route of Administration
  1.3.1 Oral
  1.3.2 Intravenous
  1.3.3 Subcutaneous Injection
1.4 Global Hereditary Angioedema Drug Segment by Application
  1.4.1 Hereditary Angioedema Drug Consumption (Sales) Comparison by Application (2012-2022)
  1.4.2 Retail Pharmacies
  1.4.3 Hospital Pharmacies
  1.4.4 Online Pharmacies
1.5 Global Hereditary Angioedema Drug Market by Region (2012-2022)
  1.5.1 Global Hereditary Angioedema Drug Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
  1.5.2 North America Status and Prospect (2012-2022)
  1.5.3 Europe Status and Prospect (2012-2022)
  1.5.4 China Status and Prospect (2012-2022)
  1.5.5 Japan Status and Prospect (2012-2022)
  1.5.6 Southeast Asia Status and Prospect (2012-2022)
  1.5.7 India Status and Prospect (2012-2022)
1.6 Global Market Size (Value) of Hereditary Angioedema Drug (2012-2022)
  1.6.1 Global Hereditary Angioedema Drug Revenue Status and Outlook (2012-2022)
  1.6.2 Global Hereditary Angioedema Drug Capacity, Production Status and Outlook (2012-2022)

2 GLOBAL HEREDITARY ANGIOEDEMA DRUG MARKET COMPETITION BY MANUFACTURERS

2.1 Global Hereditary Angioedema Drug Capacity, Production and Share by Manufacturers (2012-2017)
  2.1.1 Global Hereditary Angioedema Drug Capacity and Share by Manufacturers (2012-2017)
  2.1.2 Global Hereditary Angioedema Drug Production and Share by Manufacturers (2012-2017)
2.2 Global Hereditary Angioedema Drug Revenue and Share by Manufacturers (2012-2017)
2.3 Global Hereditary Angioedema Drug Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Hereditary Angioedema Drug Manufacturing Base Distribution, Sales Area and Product Type
2.5 Hereditary Angioedema Drug Market Competitive Situation and Trends
  2.5.1 Hereditary Angioedema Drug Market Concentration Rate
  2.5.2 Hereditary Angioedema Drug Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL HEREDITARY ANGIOEDEMA DRUG CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

3.1 Global Hereditary Angioedema Drug Capacity and Market Share by Region (2012-2017)
3.2 Global Hereditary Angioedema Drug Production and Market Share by Region (2012-2017)
3.3 Global Hereditary Angioedema Drug Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Hereditary Angioedema Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Hereditary Angioedema Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Hereditary Angioedema Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Hereditary Angioedema Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Hereditary Angioedema Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Hereditary Angioedema Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Hereditary Angioedema Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 GLOBAL HEREDITARY ANGIOEDEMA DRUG SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2012-2017)

4.1 Global Hereditary Angioedema Drug Consumption by Region (2012-2017)
4.2 North America Hereditary Angioedema Drug Production, Consumption, Export, Import (2012-2017)
4.3 Europe Hereditary Angioedema Drug Production, Consumption, Export, Import (2012-2017)
4.4 China Hereditary Angioedema Drug Production, Consumption, Export, Import (2012-2017)
4.5 Japan Hereditary Angioedema Drug Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Hereditary Angioedema Drug Production, Consumption, Export, Import (2012-2017)
4.7 India Hereditary Angioedema Drug Production, Consumption, Export, Import (2012-2017)

5 GLOBAL HEREDITARY ANGIOEDEMA DRUG PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Hereditary Angioedema Drug Production and Market Share by Type (2012-2017)
5.2 Global Hereditary Angioedema Drug Revenue and Market Share by Type (2012-2017)
5.3 Global Hereditary Angioedema Drug Price by Type (2012-2017)
5.4 Global Hereditary Angioedema Drug Production Growth by Type (2012-2017)

6 GLOBAL HEREDITARY ANGIOEDEMA DRUG MARKET ANALYSIS BY APPLICATION

6.1 Global Hereditary Angioedema Drug Consumption and Market Share by Application (2012-2017)
6.2 Global Hereditary Angioedema Drug Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL HEREDITARY ANGIOEDEMA DRUG MANUFACTURERS PROFILES/ANALYSIS

7.1 Pharming Group NV
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 Hereditary Angioedema Drug Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Pharming Group NV Hereditary Angioedema Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Main Business/Business Overview
7.2 Shire plc
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 Hereditary Angioedema Drug Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Shire plc Hereditary Angioedema Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Main Business/Business Overview
7.3 CSL Limited
  7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.3.2 Hereditary Angioedema Drug Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 CSL Limited Hereditary Angioedema Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Main Business/Business Overview
7.4 iBio Inc.
  7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.4.2 Hereditary Angioedema Drug Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 iBio Inc. Hereditary Angioedema Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Main Business/Business Overview
7.5 BioCryst Pharmaceuticals, Inc.
  7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.5.2 Hereditary Angioedema Drug Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Main Business/Business Overview
7.6 Ionis Pharmaceuticals, Inc.
  7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.6.2 Hereditary Angioedema Drug Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Main Business/Business Overview

8 HEREDITARY ANGIOEDEMA DRUG MANUFACTURING COST ANALYSIS

8.1 Hereditary Angioedema Drug Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Hereditary Angioedema Drug

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Hereditary Angioedema Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Hereditary Angioedema Drug Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL HEREDITARY ANGIOEDEMA DRUG MARKET FORECAST (2017-2022)

12.1 Global Hereditary Angioedema Drug Capacity, Production, Revenue Forecast (2017-2022)
  12.1.1 Global Hereditary Angioedema Drug Capacity, Production and Growth Rate Forecast (2017-2022)
  12.1.2 Global Hereditary Angioedema Drug Revenue and Growth Rate Forecast (2017-2022)
  12.1.3 Global Hereditary Angioedema Drug Price and Trend Forecast (2017-2022)
12.2 Global Hereditary Angioedema Drug Production, Consumption, Import and Export Forecast by Region (2017-2022)
  12.2.1 North America Hereditary Angioedema Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.2 Europe Hereditary Angioedema Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.3 China Hereditary Angioedema Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.4 Japan Hereditary Angioedema Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.5 Southeast Asia Hereditary Angioedema Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.6 India Hereditary Angioedema Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Hereditary Angioedema Drug Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Hereditary Angioedema Drug Consumption Forecast by Application (2017-2022)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Hereditary Angioedema Drug
Figure Global Hereditary Angioedema Drug Production (MT) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Hereditary Angioedema Drug Production Market Share by Types (Product Category) in 2016
Figure Product Picture of C1 Esterase Inhibitor
Table Major Manufacturers of C1 Esterase Inhibitor
Figure Product Picture of Kallikrein Inhibitor
Table Major Manufacturers of Kallikrein Inhibitor
Figure Product Picture of Selective Bradykinin B2 Receptor Antagonist
Table Major Manufacturers of Selective Bradykinin B2 Receptor Antagonist
Figure Global Hereditary Angioedema Drug Consumption (MT) by Applications (2012-2022)
Figure Global Hereditary Angioedema Drug Consumption Market Share by Applications in 2016
Figure Retail Pharmacies Examples
Table Key Downstream Customer in Retail Pharmacies
Figure Hospital Pharmacies Examples
Table Key Downstream Customer in Hospital Pharmacies
Figure Online Pharmacies Examples
Table Key Downstream Customer in Online Pharmacies
Figure Global Hereditary Angioedema Drug Market Size (Million USD), Comparison (MT) and CAGR (%) by Regions (2012-2022)
Figure North America Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Hereditary Angioedema Drug Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Hereditary Angioedema Drug Capacity, Production (MT) Status and Outlook (2012-2022)
Figure Global Hereditary Angioedema Drug Major Players Product Capacity (MT) (2012-2017)
Table Global Hereditary Angioedema Drug Capacity (MT) of Key Manufacturers (2012-2017)
Table Global Hereditary Angioedema Drug Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Hereditary Angioedema Drug Capacity (MT) of Key Manufacturers in 2016
Figure Global Hereditary Angioedema Drug Capacity (MT) of Key Manufacturers in 2017
Figure Global Hereditary Angioedema Drug Major Players Product Production (MT) (2012-2017)
Table Global Hereditary Angioedema Drug Production (MT) of Key Manufacturers (2012-2017)
Table Global Hereditary Angioedema Drug Production Share by Manufacturers (2012-2017)
Figure 2016 Hereditary Angioedema Drug Production Share by Manufacturers
Figure 2017 Hereditary Angioedema Drug Production Share by Manufacturers
Figure Global Hereditary Angioedema Drug Major Players Product Revenue (Million USD) (2012-2017)
Table Global Hereditary Angioedema Drug Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Hereditary Angioedema Drug Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Hereditary Angioedema Drug Revenue Share by Manufacturers
Table 2017 Global Hereditary Angioedema Drug Revenue Share by Manufacturers
Table Global Market Hereditary Angioedema Drug Average Price (USD/Kg) of Key Manufacturers (2012-2017)
Figure Global Market Hereditary Angioedema Drug Average Price (USD/Kg) of Key Manufacturers in 2016
Table Manufacturers Hereditary Angioedema Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Hereditary Angioedema Drug Product Category
Figure Hereditary Angioedema Drug Market Share of Top 3 Manufacturers
Figure Hereditary Angioedema Drug Market Share of Top 5 Manufacturers
Table Global Hereditary Angioedema Drug Capacity (MT) by Region (2012-2017)
Figure Global Hereditary Angioedema Drug Capacity Market Share by Region (2012-2017)
Figure Global Hereditary Angioedema Drug Capacity Market Share by Region (2012-2017)
Figure 2016 Global Hereditary Angioedema Drug Capacity Market Share by Region
Table Global Hereditary Angioedema Drug Production by Region (2012-2017)
Figure Global Hereditary Angioedema Drug Production (MT) by Region (2012-2017)
Figure Global Hereditary Angioedema Drug Production Market Share by Region (2012-2017)
Figure 2016 Global Hereditary Angioedema Drug Production Market Share by Region
Table Global Hereditary Angioedema Drug Revenue (Million USD) by Region (2012-2017)
Table Global Hereditary Angioedema Drug Revenue Market Share by Region (2012-2017)
Figure Global Hereditary Angioedema Drug Revenue Market Share by Region (2012-2017)
Table 2016 Global Hereditary Angioedema Drug Revenue Market Share by Region
Figure Global Hereditary Angioedema Drug Capacity, Production (MT) and Growth Rate (2012-2017)
Table Global Hereditary Angioedema Drug Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Table North America Hereditary Angioedema Drug Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Table Europe Hereditary Angioedema Drug Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Table China Hereditary Angioedema Drug Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Table Japan Hereditary Angioedema Drug Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Table Southeast Asia Hereditary Angioedema Drug Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Table India Hereditary Angioedema Drug Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Table Global Hereditary Angioedema Drug Consumption (MT) Market by Region (2012-2017)
Table Global Hereditary Angioedema Drug Consumption Market Share by Region (2012-2017)
Figure Global Hereditary Angioedema Drug Consumption Market Share by Region (2012-2017)
Figure 2016 Global Hereditary Angioedema Drug Consumption (MT) Market Share by Region
Table North America Hereditary Angioedema Drug Production, Consumption, Import & Export (MT) (2012-2017)
Table Europe Hereditary Angioedema Drug Production, Consumption, Import & Export (MT) (2012-2017)
Table China Hereditary Angioedema Drug Production, Consumption, Import & Export (MT) (2012-2017)
Table Japan Hereditary Angioedema Drug Production, Consumption, Import & Export (MT) (2012-2017)
Table Southeast Asia Hereditary Angioedema Drug Production, Consumption, Import & Export (MT) (2012-2017)
Table India Hereditary Angioedema Drug Production, Consumption, Import & Export (MT) (2012-2017)
Table Global Hereditary Angioedema Drug Production (MT) by Type (2012-2017)
Table Global Hereditary Angioedema Drug Production Share by Type (2012-2017)
Figure Production Market Share of Hereditary Angioedema Drug by Type (2012-2017)
Figure 2016 Production Market Share of Hereditary Angioedema Drug by Type
Table Global Hereditary Angioedema Drug Revenue (Million USD) by Type (2012-2017)
Table Global Hereditary Angioedema Drug Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Hereditary Angioedema Drug by Type (2012-2017)
Figure 2016 Revenue Market Share of Hereditary Angioedema Drug by Type
Table Global Hereditary Angioedema Drug Price (USD/Kg) by Type (2012-2017)
Figure Global Hereditary Angioedema Drug Production Growth by Type (2012-2017)
Table Global Hereditary Angioedema Drug Consumption (MT) by Application (2012-2017)
Table Global Hereditary Angioedema Drug Consumption Market Share by Application (2012-2017)
Figure Global Hereditary Angioedema Drug Consumption Market Share by Applications (2012-2017)
Figure Global Hereditary Angioedema Drug Consumption Market Share by Application in 2016
Table Global Hereditary Angioedema Drug Consumption Growth Rate by Application (2012-2017)
Figure Global Hereditary Angioedema Drug Consumption Growth Rate by Application (2012-2017)
Table Pharming Group NV Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pharming Group NV Hereditary Angioedema Drug Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Pharming Group NV Hereditary Angioedema Drug Production Growth Rate (2012-2017)
Figure Pharming Group NV Hereditary Angioedema Drug Production Market Share (2012-2017)
Figure Pharming Group NV Hereditary Angioedema Drug Revenue Market Share (2012-2017)
Table Shire plc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Shire plc Hereditary Angioedema Drug Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Shire plc Hereditary Angioedema Drug Production Growth Rate (2012-2017)
Figure Shire plc Hereditary Angioedema Drug Production Market Share (2012-2017)
Figure Shire plc Hereditary Angioedema Drug Revenue Market Share (2012-2017)
Table CSL Limited Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CSL Limited Hereditary Angioedema Drug Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure CSL Limited Hereditary Angioedema Drug Production Growth Rate (2012-2017)
Figure CSL Limited Hereditary Angioedema Drug Production Market Share (2012-2017)
Figure CSL Limited Hereditary Angioedema Drug Revenue Market Share (2012-2017)
Table iBio Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table iBio Inc. Hereditary Angioedema Drug Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure iBio Inc. Hereditary Angioedema Drug Production Growth Rate (2012-2017)
Figure iBio Inc. Hereditary Angioedema Drug Production Market Share (2012-2017)
Figure iBio Inc. Hereditary Angioedema Drug Revenue Market Share (2012-2017)
Table BioCryst Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Production Growth Rate (2012-2017)
Figure BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Production Market Share (2012-2017)
Figure BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Revenue Market Share (2012-2017)
Table Ionis Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Production Growth Rate (2012-2017)
Figure Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Production Market Share (2012-2017)
Figure Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hereditary Angioedema Drug
Figure Manufacturing Process Analysis of Hereditary Angioedema Drug
Figure Hereditary Angioedema Drug Industrial Chain Analysis
Table Raw Materials Sources of Hereditary Angioedema Drug Major Manufacturers in 2016
Table Major Buyers of Hereditary Angioedema Drug
Table Distributors/Traders List
Figure Global Hereditary Angioedema Drug Capacity, Production (MT) and Growth Rate Forecast (2017-2022)
Figure Global Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Hereditary Angioedema Drug Price (Million USD) and Trend Forecast (2017-2022)
Table Global Hereditary Angioedema Drug Production (MT) Forecast by Region (2017-2022)
Figure Global Hereditary Angioedema Drug Production Market Share Forecast by Region (2017-2022)
Table Global Hereditary Angioedema Drug Consumption (MT) Forecast by Region (2017-2022)
Figure Global Hereditary Angioedema Drug Consumption Market Share Forecast by Region (2017-2022)
Figure North America Hereditary Angioedema Drug Production (MT) and Growth Rate Forecast (2017-2022)
Figure North America Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Hereditary Angioedema Drug Production, Consumption, Export and Import (MT) Forecast (2017-2022)
Figure Europe Hereditary Angioedema Drug Production (MT) and Growth Rate Forecast (2017-2022)
Figure Europe Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Hereditary Angioedema Drug Production, Consumption, Export and Import (MT) Forecast (2017-2022)
Figure China Hereditary Angioedema Drug Production (MT) and Growth Rate Forecast (2017-2022)
Figure China Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Hereditary Angioedema Drug Production, Consumption, Export and Import (MT) Forecast (2017-2022)
Figure Japan Hereditary Angioedema Drug Production (MT) and Growth Rate Forecast (2017-2022)
Figure Japan Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Hereditary Angioedema Drug Production, Consumption, Export and Import (MT) Forecast (2017-2022)
Figure Southeast Asia Hereditary Angioedema Drug Production (MT) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Hereditary Angioedema Drug Production, Consumption, Export and Import (MT) Forecast (2017-2022)
Figure India Hereditary Angioedema Drug Production (MT) and Growth Rate Forecast (2017-2022)
Figure India Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Hereditary Angioedema Drug Production, Consumption, Export and Import (MT) Forecast (2017-2022)
Table Global Hereditary Angioedema Drug Production (MT) Forecast by Type (2017-2022)
Figure Global Hereditary Angioedema Drug Production (MT) Forecast by Type (2017-2022)
Table Global Hereditary Angioedema Drug Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Hereditary Angioedema Drug Revenue Market Share Forecast by Type (2017-2022)
Table Global Hereditary Angioedema Drug Price Forecast by Type (2017-2022)
Table Global Hereditary Angioedema Drug Consumption (MT) Forecast by Application (2017-2022)
Figure Global Hereditary Angioedema Drug Consumption (MT) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source